Toxic iron species in lower-risk myelodysplastic syndrome patients : course of disease and effects on outcome

Autor: Hoeks, Marlijn, Bagguley, Tim, van Marrewijk, Corine, Smith, Alex, Bowen, David, Culligan, Dominic, Kolade, Seye, Symeonidis, Argiris, Garelius, Hege, Spanoudakis, Michail, Langemeijer, Saskia, Roelofs, Rian, Wiegerinck, Erwin, Tatic, Aurelia, Killick, Sally, Panagiotidis, Panagiotis, Stanca, Oana, Hellström-Lindberg, Eva, Cermak, Jaroslav, van der Klauw, Melanie, Wouters, Hanneke, van Kraaij, Marian, Blijlevens, Nicole, Swinkels, Dorine W., de Witte, Theo, Stauder, R., Walder, A., Pfeilstöcker, M., Schoenmetzler-Makrai, A., Burgstaller, S., Thaler, J., Mandac Rogulj, I., Krejci, M., Voglova, J., Rohon, P., Jonasova, A., Cermak, J., Mikulenkova, D., Hochova, I., Jensen, P. D., Holm, M. S., Kjeldsen, L., Dufva, I. H., Vestergaard, H., Re, D., Slama, B., Fenaux, P., Choufi, B., Cheze, S., Klepping, D., Salles, B., de Renzis, B., Willems, L., De Prost, D., Gutnecht, J., Courby, S., Siguret, V., Tertian, G., Pascal, L., Chaury, M., Wattel, E., Guerci, A., Legros, L., Itzykson, R., Ades, L., Isnard, F., Sanhes, L., Benramdane, R., Stamatoullas, A., Amé, S., Beyne-Rauzy, O., Gyan, E., Platzbecker, U., Badrakan, C., Germing, U., Lübbert, M., Schlenk, R., Kotsianidis, I., Tsatalas, C., Pappa, V., Galanopoulos, A., Michali, E., Panagiotidis, P., Viniou, N., Katsigiannis, A., Roussou, P., Terpos, E., Kostourou, A., Kartasis, Z., Pouli, A., Palla, K., Briasoulis, V., Hatzimichael, E., Vassilopoulos, G., Symeonidis, A., Kourakli, A., Zikos, P., Anagnostopoulos, A., Kotsopoulou, M., Megalakaki, K., Protopapa, M., Vlachaki, E., Konstantinidou, P., Stemer, G., Nemetz, A., Gotwin, U., Cohen, O., Koren, M., Levy, E., Greenbaum, U., Gino-Moor, S., Price, M., Ofran, Y., Winder, A., Goldshmidt, N., Elias, S., Sabag, R., Hellman, I., Ellis, M., Braester, A., Rosenbaum, H., Berdichevsky, S., Itzhaki, G., Wolaj, O., Yeganeh, S., Katz, O., Filanovsky, K., Dali, N., Mittelman, M., Malcovati, L., Fianchi, L., vd Loosdrecht, A., Matthijssen, V., Herbers, A., Pruijt, H., Aboosy, N., de Vries, F., Velders, G., Jacobs, E., Langemeijer, S., MacKenzie, M., Lensen, C., Kuijper, P., Madry, K., Camara, M., Almeida, A., Vulkan, G., Stanca Ciocan, O., Tatic, A., Savic, A., Pedro, C., Xicoy, B., Leiva, P., Munoz, J., Betes, V., Benavente, C., Lozano, M., Martinez, M., Iniesta, P., Bernal, T., Diez Campelo, M., Tormo, D., Andreu Lapiedra, R., Sanz, G., Hesse Sundin, E., Garelius, H., Karlsson, C., Antunovic, P., Jönsson, A., Brandefors, L., Nilsson, L., Kozlowski, P., Hellstrom-Lindberg, E., Grövdal, M., Larsson, K., Wallvik, J., Lorenz, F., Ejerblad, E., Culligan, D., Craddock, C., Kolade, S., Cahalin, P., Killick, S., Ackroyd, S., Wong, C., Warren, A., Drummond, M., Hall, C., Rothwell, K., Green, S., Ali, S., Bowen, D., Karakantza, M., Dennis, M., Jones, G., Parker, J., Bowen, A., Radia, R., Das-Gupta, E., Vyas, P., Nga, E., Creagh, D., Ashcroft, J., Mills, J., Bond, L.

Publikováno v: Hoeks, M, Bagguley, T, van Marrewijk, C, Smith, A, Bowen, D, Culligan, D, Kolade, S, Symeonidis, A, Garelius, H, Spanoudakis, M, Langemeijer, S, Roelofs, R, Wiegerinck, E, Tatic, A, Killick, S, Panagiotidis, P, Stanca, O, Hellström-Lindberg, E, Cermak, J, van der Klauw, M, Wouters, H, van Kraaij, M, Blijlevens, N, Swinkels, D W, de Witte, T, Stauder, R, Walder, A, Pfeilstöcker, M, Schoenmetzler-Makrai, A, Burgstaller, S, Thaler, J, Mandac Rogulj, I, Krejci, M, Voglova, J, Rohon, P, Jonasova, A, Cermak, J, Mikulenkova, D, Hochova, I, Jensen, P D, Holm, M S, Kjeldsen, L, Dufva, I H, Vestergaard, H, Re, D, Slama, B, Fenaux, P, Choufi, B, Cheze, S, Klepping, D, Salles, B, de Renzis, B, Willems, L, De Prost, D, Gutnecht, J, Courby, S, Siguret, V, Tertian, G, Pascal, L, Chaury, M, Wattel, E, Guerci, A, Legros, L, Itzykson, R, Ades, L, Isnard, F, Sanhes, L, Benramdane, R, Stamatoullas, A, Amé, S, Beyne-Rauzy, O, Gyan, E, Platzbecker, U, Badrakan, C, Germing, U, Lübbert, M, Schlenk, R, Kotsianidis, I, Tsatalas, C, Pappa, V, Galanopoulos, A, Michali, E, Panagiotidis, P, Viniou, N, Katsigiannis, A, Roussou, P, Terpos, E, Kostourou, A, Kartasis, Z, Pouli, A, Palla, K, Briasoulis, V, Hatzimichael, E, Vassilopoulos, G, Symeonidis, A, Kourakli, A, Zikos, P, Anagnostopoulos, A, Kotsopoulou, M, Megalakaki, K, Protopapa, M, Vlachaki, E, Konstantinidou, P, Stemer, G, Nemetz, A, Gotwin, U, Cohen, O, Koren, M, Levy, E, Greenbaum, U, Gino-Moor, S, Price, M, Ofran, Y, Winder, A, Goldshmidt, N, Elias, S, Sabag, R, Hellman, I, Ellis, M, Braester, A, Rosenbaum, H, Berdichevsky, S, Itzhaki, G, Wolaj, O, Yeganeh, S, Katz, O, Filanovsky, K, Dali, N, Mittelman, M, Malcovati, L, Fianchi, L, vd Loosdrecht, A, Matthijssen, V, Herbers, A, Pruijt, H, Aboosy, N, de Vries, F, Velders, G, Jacobs, E, Langemeijer, S, MacKenzie, M, Lensen, C, Kuijper, P, Madry, K, Camara, M, Almeida, A, Vulkan, G, Stanca Ciocan, O, Tatic, A, Savic, A, Pedro, C, Xicoy, B, Leiva, P, Munoz, J, Betes, V, Benavente, C, Lozano, M, Martinez, M, Iniesta, P, Bernal, T, Diez Campelo, M, Tormo, D, Andreu Lapiedra, R, Sanz, G, Hesse Sundin, E, Garelius, H, Karlsson, C, Antunovic, P, Jönsson, A, Brandefors, L, Nilsson, L, Kozlowski, P, Hellstrom-Lindberg, E, Grövdal, M, Larsson, K, Wallvik, J, Lorenz, F, Ejerblad, E, Culligan, D, Craddock, C, Kolade, S, Cahalin, P, Killick, S, Ackroyd, S, Wong, C, Warren, A, Drummond, M, Hall, C, Rothwell, K, Green, S, Ali, S, Karakantza, M, Dennis, M, Jones, G, Parker, J, Bowen, A, Radia, R, Das-Gupta, E, Vyas, P, Nga, E, Creagh, D, Ashcroft, J, Mills, J, Bond, L & the EUMDS Registry Participants 2021, ' Toxic iron species in lower-risk myelodysplastic syndrome patients : course of disease and effects on outcome ', Leukemia, vol. 35, no. 6, pp. 1745-1750 . https://doi.org/10.1038/s41375-020-01022-2
on behalf of the EUMDS Registry Participants 2021, ' Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome ', Leukemia, vol. 35, no. 6, pp. 1745-1750 . https://doi.org/10.1038/s41375-020-01022-2
Hoeks, M, Bagguley, T, van Marrewijk, C, Smith, A, Bowen, D, Culligan, D, Kolade, S, Symeonidis, A, Garelius, H, Spanoudakis, M, Langemeijer, S, Roelofs, R, Wiegerinck, E, Tatic, A, Killick, S, Panagiotidis, P, Stanca, O, Hellström-Lindberg, E, Cermak, J, van der Klauw, M, Wouters, H, van Kraaij, M, Blijlevens, N, Swinkels, D W, de Witte, T, on behalf of the EUMDS Registry Participants & Vestergaard, H 2021, ' Toxic iron species in lower-risk myelodysplastic syndrome patients : course of disease and effects on outcome ', Leukemia, vol. 35, no. 6, pp. 1745-1750 . https://doi.org/10.1038/s41375-020-01022-2
Leukemia, 35, 1745-1750
Leukemia, 35, 1745-1750. Nature Publishing Group
Leukemia, 35(6), 1745-1750. Nature Publishing Group
Leukemia, 35, 6, pp. 1745-1750
Leukemia

Red blood cell transfusions (RBCT) remain the cornerstone of supportive care in lower-risk myelodysplastic syndrome (LRMDS) [1]. Transfusion dependency in LRMDS patients is associated with inferior outcomes, mainly attributed to severe bone marrow fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23cc5efb8d641ceed6da88864dd77a4
https://eprints.whiterose.ac.uk/165856/1/s41375_020_01022_2.pdf

Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.

Autor: Vassilakopoulos TP; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Michail M; Department of Hematology, Nicosia General Hospital, Nicosia, Cyprus., Papageorgiou S; Second Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece., Kourti G; Third Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.; Department of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece., Angelopoulou MK; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Panitsas F; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Sachanas S; Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece., Kalpadakis C; Department of Hematology, University of Crete, Iraklion, Crete, Greece., Katodritou E; Department of Hematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece., Leonidopoulou T; Department of Hematology, Sismanoglion General Hospital, Athens, Greece., Kotsianidis I; Department of Hematology, Democritus University of Thrace, Alexandroupolis, Greece., Hatzimichael E; Department of Hematology, University of Ioannina, Ioannina, Greece., Kotsopoulou M; Department of Hematology, Metaxa Anticancer Hospital, Piraeus, Greece., Dimou M; First Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Variamis E; First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Boutsis D; Department of Hematology, Athens Navy Hospital, Athens, Greece., Terpos E; Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece., Dimopoulou MN; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Karakatsanis S; Third Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece., Michalis E; Department of Clinical Hematology, 'G.Gennimatas' Athens General Hospital, Athens, Greece., Karianakis G; Department of Hematology, HYGEIA Hospital, Athens, Greece., Tsirkinidis P; Department of Hematology, 401 Army Hospital, Athens, Greece., Vadikolia C; Department of Hematology, 424 Army Hospital, Thessaloniki, Greece., Poziopoulos C; Department of Hematology, Metropolitan Hospital, N. Faliron, Athens, Greece., Pigaditou A; Department of Hematology, Athens Medical Center, Amaroussion Branch, Athens, Greece., Vrakidou E; Department of Hematology, HYGEIA Hospital, Athens, Greece., Economopoulos T; Department of Hematology, Athens Medical Center, Amaroussion Branch, Athens, Greece., Kyriazopoulou L; Department of Hematology, University of Ioannina, Ioannina, Greece., Siakantaris MP; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Kyrtsonis MC; First Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Symeonidis A; Hematology Division, Dept of Internal Medicine, University of Patras, Patras, Greece., Anargyrou K; Department of Hematology, 251 Air Force Hospital, Athens, Greece., Papaioannou M; Hematology Unit, 1st Dept of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Hatjiharissi E; Department of Hematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece.; Hematology Unit, 1st Dept of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Vervessou E; Department of Hematology, Henry Dynant Hospital, Athens, Greece., Tsirogianni M; Department of Hematology, Aghios Savvas Anticancer Hospital, Athens, Greece., Palassopoulou M; Department of Hematology, University of Thessalia Hospital, Larissa, Greece., Gainaru G; Department of Hematology, HYGEIA Hospital, Athens, Greece., Stefanoudaki E; Department of Hematology, Amalia Fleming Hospital, Athens, Greece., Zikos P; Hematology Division, Aghios Andreas Hospital, Patras, Greece., Tsirigotis P; Second Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece., Tsourouflis G; Second Propedeutic Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Assimakopoulou T; Department of Hematology, Sismanoglion General Hospital, Athens, Greece., Konstantinidou P; Department of Hematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece., A Papadaki H; Department of Hematology, University of Crete, Iraklion, Crete, Greece., Megalakaki K; Department of Hematology, Metaxa Anticancer Hospital, Piraeus, Greece., Dimopoulos MA; Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece., Pappa V; Second Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece., Karmiris T; Department of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece., Roussou P; Third Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece., Panayiotidis P; First Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Konstantopoulos K; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Pangalis GA; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.; Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece.

Publikováno v: The oncologist [Oncologist] 2021 Jul; Vol. 26 (7), pp. 597-609. Date of Electronic Publication: 2021 Jun 17.

BUDGET IMPACT ANALYSIS OF PANOBINOSTAT - BORTEZOMIB AND DEXAMETHASONE, AS 3RD OR 4TH LINE OF TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN GREECE

Autor: Vellopoulou, K. Kourlaba, G. Delimpasi, S. Chatzikou, M. and Katodritou, E. Konstantopoulou, K. Megalakaki, K. Pouli, A. and Repousis, P. Terpos, E.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::ab5430d946b2de2946984423904a557a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3171748

PHS33 - The Management and Costs of Multiple Myeloma in Greece: Mapping the Local Treatment Pathway and Associated Resource Use

Autor: Siskou, O, Kaitelidou, D, Delimpasi, S, Katodritou, E, Megalakaki, K, Pouli, A, Repousis, P, Terpos, E, Kalogeropoulou, M, Florini, S, Konstantakopoulou, O, Goranitis, I, Liaropoulos, L, Dimopoulos, MA

Publikováno v: In Value in Health November 2016 19(7):A609-A609

Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse.

Autor: Papanikolaou X; First Department of Propaedeutic Internal Medicine-Hematology Section, Laikon University Hospital, Athens, Greece., Repousis P, Tzenou T, Maltezas D, Kotsopoulou M, Megalakaki K, Angelopoulou M, Dimitrakoloulou E, Koulieris E, Bartzis V, Pangalis G, Panayotidis P, Kyrtsonis MC

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2013 Jul; Vol. 54 (7), pp. 1459-64. Date of Electronic Publication: 2012 Dec 14.